investorscraft@gmail.com

Pacira BioSciences, Inc. (PCRX)

Previous Close
$22.90
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)90.69296
Intrinsic value (DCF)4.79-79
Graham-Dodd Method6.07-74
Graham Formulan/a

Company Information

5401 West Kennedy Boulevard
Tampa, FL 33609
United States
Phone: 813 553 6680
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: Mr. Frank D. Lee
Full Time Employees: 788

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

HomeMenuAccount